|
|
||||||||
B activation and
attenuates myocardial reperfusion injury
Departments of 2 Internal Medicine and 3 Emergency Medicine and the Cannon Research Center, Carolinas Medical Center, Charlotte, North Carolina 28232; 1 Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine and 4 Carlyle Fraser Heart Center Cardiothoracic Research Laboratory, Crawford Long Hospital, Atlanta, Georgia 30365; and 5 Division of Respiratory, Critical Care and Occupational (Pulmonary) Medicine, University of Utah, Salt Lake City, Utah 84132
Heparin reduces
ischemia-reperfusion injury to myocardium. This effect has been
attributed to complement inhibition, but heparin also has other
activities that might diminish ischemia-reperfusion. To further probe
these mechanisms, we compared heparin or an o-desulfated nonanticoagulant heparin with greatly reduced anticomplement activity. When given at the time of coronary artery reperfusion in a canine model
of myocardial infarction, heparin or o-desulfated heparin equally reduced neutrophil adherence to ischemic-reperfused coronary artery endothelium, influx of neutrophils into ischemic-reperfused myocardium, myocardial necrosis, and release of creatine kinase into
plasma. Heparin or o-desulfated heparin also prevented
dysfunction of endothelial-dependent coronary relaxation following
ischemic injury. In addition, heparin and o-desulfated
heparin inhibited translocation of the transcription nuclear
factor-
B (NF-
B) from the cytoplasm to the nucleus in human
endothelial cells and decreased NF-
B DNA binding in human
endothelium and ischemic-reperfused rat myocardium. Thus heparin and
nonanticoagulant heparin decrease ischemia-reperfusion injury by
disrupting multiple levels of the inflammatory cascade, including the
novel observation that heparins inhibit activation of the
proinflammatory transcription factor NF-
B.
ischemia-reperfusion; myocardial infarction; endothelium neutrophils; endothelial dysfunction
This article has been cited by other articles:
![]() |
B. Dixon, J. Santamaria, and D. Campbell Coagulation Activation and Organ Dysfunction Following Cardiac Surgery Chest, July 1, 2005; 128(1): 229 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rossi, G. Sganga, M. Mazzone, V. Valenza, S. Guarneri, G. Portale, L. Carbone, L. Gatta, C. Pioli, M. Sanguinetti, et al. Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation Ann. Thorac. Surg., February 1, 2004; 77(2): 612 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wright, I. S. Singh, J. D. Hasday, I. K. Farrance, G. Hall, A. S. Cross, and T. B. Rogers Endotoxin stress-response in cardiomyocytes: NF-kappa B activation and tumor necrosis factor-alpha expression Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H872 - H879. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |